Organization (Other)
Sheikh Zayed Federal Postgraduate Medical Institute
ClinicalTrials.gov lists Sheikh Zayed Federal Postgraduate Medical Institute as lead sponsor of 13 trials. It has 16 active development programs and 4 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs. 1 trial is registered to start in 2027 or later.
This page covers Sheikh Zayed Federal Postgraduate Medical Institute: 13 lead-sponsored trials and 0 legal-entity registrations.
Disease areas (23)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Hemorrhage | 2 |
| Alopecia | 1 |
| Arthritis, Rheumatoid | 1 |
| Coronary Disease | 1 |
| Dental Caries | 1 |
Showing 5 of 23 disease areas.
Trials by start year as sponsor or collaborator (10)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2017 | 1 |
| 2012 | 3 |
| 2010 | 1 |
| 2008 | 1 |
Recruitment duration, a model prediction: none of the 13 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (16)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Minoxidil | Alopecia | Phase 3 | 1 |
| Minoxidil 5 % Topical Spray | Alopecia | Phase 3 | 1 |
| Statin monotherapy (rosuvastatin or atorvastatin) | ST Elevation Myocardial Infarction | Phase 2 | 1 |
| Statin monotherapy (rosuvastatin or atorvastatin) | Myocardial Infarction | Phase 2 | 1 |
| Chlorhexidine Topical Cream | Neonatal Sepsis | Phase 2 | 1 |
Showing 5 of 16 active programs.
Approved assets (4)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| JAK inhibitor(tofacitinib/upadacitinib) as advised by the rheumatologist as add on to 25 mg methotrexate | 1 |
| Minoxidil | 1 |
| Adrenaline | 1 |
| Tranexamic Acid | 1 |
Journals published in (10)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 3 |
| African journal of emergency medicine : Revue africaine de la medecine d'urgence | 1 |
| American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics | 1 |
| Brazilian dental journal | 1 |
| Clinical otolaryngology and allied sciences | 1 |
Showing 5 of 10 journals.
Latest dated events (15)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-04 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-03-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-20 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-12-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 15 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| GOPC | Trial sponsor | Named in trial exclusion criteria |
| GOPC | Trial sponsor | Mentioned in trial text |
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.